Beacon Therapeutics

Beacon Therapeutics is an ophthalmic gene therapy company established in 2023 with a mission to save and restore vision for patients suffering from a range of prevalent and rare retinal diseases that lead to blindness. The company focuses on developing innovative AAV gene therapies and has a diverse pipeline including a late-stage development candidate for X-linked retinitis pigmentosa (XLRP), as well as preclinical programs targeting dry age-related macular degeneration (dAMD) and cone-rod dystrophy (CRD). Beacon Therapeutics is supported by a strong team of researchers, developers, and clinicians, and is committed to bringing its treatments to patients through a robust clinical trial program.

Beacon Therapeutics is headquartered in Cambridge, Massachusetts, with offices in Alachua, Florida, and London, UK. The company is supported by a diverse group of investors including Syncona Limited, Forbion, Oxford Science Enterprises, TCGX, Advent Life Sciences, and other private investors. The company is also actively seeking new talent to join their team and help deliver their mission to transform the lives of patients with blinding retinal diseases.

Beacon Therapeutics is an ophthalmic gene therapy company committed to saving and restoring vision for patients suffering from a range of prevalent and rare retinal diseases that cause blindness. They aim to achieve this through innovative AAV gene therapy, focusing on diseases like X-linked retinitis pigmentosa, dry age-related macular degeneration, and cone-rod dystrophy. Beacon is driven by a strong scientific foundation, a diverse pipeline of late-stage and preclinical programs, and a highly experienced management team, all working towards bringing transformative treatments to patients.

Beacon Therapeutics promotes a culture of innovation and collaboration, focused on delivering pioneering ocular gene therapies to restore vision for patients with blinding retinal diseases. Their website emphasizes the importance of teamwork, passion, and a drive to make a difference in the lives of patients. They actively seek out new talent who share these values and are motivated to be part of their transformational science.

Beacon Therapeutics is committed to fostering a diverse, equitable, and inclusive workplace, recognizing that a variety of perspectives and backgrounds are essential to achieving its mission of restoring vision to patients. This commitment is demonstrated through initiatives that promote equal opportunities for all employees, including those with diverse ethnic origins, genders, and professional experiences. The company actively works to build a culture where everyone feels valued, respected, and empowered to contribute their unique talents.